Bimeda USA Link

Safe & Effective

Facts are facts, regardless of what other companies may be telling you. In gaining approval from the U.S. Food and Drug Administration (FDA), Macrosyn™ was granted the same label claims as Draxxin® and is bioequivalent to the pioneer product in:

  • Active ingredient & inactive ingredients (including carriers and excipients)
  • Strength, dosage form & route of administration

Additionally, Macrosyn meets the same quality and safety requirements and is manufactured at an approved FDA facility.

tulathromycin isomersMacrosyn Injectable Solution consists of an equilibrated mixture of two isomeric forms of tulathromycin in a 9:1 ratio
 

See How Macrosyn Stacks Up Against Draxxin

*See label for complete product information.Draxxin is a registered trademark of Zoetis Inc.

back to top

Important Safety Information

Important Safety Information for Cattle: Do not use in female dairy cattle 20 months of age or older, including dry dairy cows. Effects on reproductive performance, pregnancy and lactation have not been determined. Macrosyn has a pre-slaughter withdrawal time of 18 days. Macrosyn should not be used in animals known to be hypersensitive to the product.

Important Safety Information for Swine: The pre-slaughter withdrawal time for Macrosyn in swine is five days. Macrosyn should not be used in animals known to be hypersensitive to the product. Effects on reproductive performance, pregnancy, and lactation have not been determined.

Draxxin is a registered trademark of Zoetis Inc.